Subscribe To
Agios pharmaceuticals to present broad set of clinical and translational data in rare blood disorders at 65th ash annual meeting and exposition
– Both Mitapivat Dose Arms Achieved Statistically Significant Hemoglobin Response in Phase 2 Portion of RISE UP Pivotal Study in Sickle Cell Disease...
November 2, 2023, 9:05 am
Siren biotechnology awarded $4m in grant funding from the california institute for regenerative medicine (cirm)
SAN FRANCISCO, Nov. 01, 2023 (GLOBE NEWSWIRE) — Siren Biotechnology, a gene therapy company pioneering Universal AAV Immuno-Gene Therapies for Cance...
November 1, 2023, 4:46 pm
Gri bio announces partnership with the respiratory translational research collaboration to advance leading nkt regulation technology targeting earlier in the inflammatory cascade to modulate disease p
UK consortia brings together internationally recognized investigators in the UK’s leading centers of excellence to carry out experimental and early ...
October 17, 2023, 12:35 pm
Sana biotechnology announces increased focus on hypoimmune-related pipeline with the potential to deliver clinical proof of concept data from four programs in 2023 and 2024 with a 2024 operating burn
Increasing focus on ex vivo cell therapy platform based on extensive preclinical and early translational...
October 10, 2023, 8:15 pm
Mink therapeutics to present data update from allogeneic inkt cells in solid tumors at sitc 2023
NEW YORK, Sept. 27, 2023 (GLOBE NEWSWIRE) -- MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering the discove...
September 27, 2023, 9:05 am
Addex therapeutics to release half-year 2023 financial results and host conference call on august 10, 2023
Geneva, Switzerland, August 3 , 2023 – Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modu...
August 4, 2023, 1:00 am
Cellectis presents updated clinical and translational data on balli-01 at the european hematology association (eha) 2023
NEW YORK, June 09, 2023 (GLOBE NEWSWIRE) — Cellectis (the “Company”) (Euronext Growth: ALCLS – NASDAQ: CLLS), a clinical-stage biotechnology c...
June 9, 2023, 8:30 pm
Regeneron pharmaceuticals, inc. (regn) td cowen 4th annual oncology innovation summit (transcript)
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN ) TD Cowen 4th Annual Oncology Innovation Summit May 30, 2023 12:30 PM ET Company Participants Izzy Lowy ...
May 30, 2023, 3:18 pm
Arrowhead pharmaceuticals, inc. (arwr) q2 2023 earnings call transcript
Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR ) Q2 2023 Earnings Conference Call May 2, 2023 4:30 PM ET Company Participants Vincent Anzalone - Vice Pr...
May 2, 2023, 8:42 pm
Cabaletta bio to present at the american society of gene and cell therapy 26th annual meeting
PHILADELPHIA, May 02, 2023 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on developing and la...
May 2, 2023, 4:35 pm
Sana biotechnology announces preclinical data published in science translational medicine showing its hypoimmune pancreatic islet cells evaded allogeneic and autoimmune rejection and controlled type 1
Hypoimmune human islet cells normalized glucose in diabetic humanized immunocompetent mouse model and avoided allogeneic and autoimmune rejection by t...
April 12, 2023, 8:05 pm
Sana biotechnology announces preclinical data published in science translational medicine showing its hypoimmune pancreatic islet cells evaded allogeneic and autoimmune rejection and controlled type 1
Hypoimmune human islet cells normalized glucose in diabetic humanized immunocompetent mouse model and avoided allogeneic and autoimmune rejection by t...
April 12, 2023, 8:05 pm
Predictive oncology appoints translational research leader christoph reinhard to scientific advisory board
Predictive Oncology Inc. (NASDAQ:POAI) announced the appointment of Dr. Christoph Reinhard to its scientific board to serve alongside other key though...
April 4, 2023, 9:34 am
Cue biopharma, inc. (cue) q4 2022 earnings call transcript
Cue Biopharma, Inc. (NASDAQ:CUE ) Q4 2022 Earnings Conference Call March 21, 2023 4:30 PM ET Company Participants Dan Passeri - CEO Matteo Levisetti -...
March 21, 2023, 11:00 pm
Alaunos therapeutics reports fourth quarter and full year 2022 financial results
Generated cutting-edge translational data demonstrating safety, persistence and functionality of infuse...
March 7, 2023, 12:00 pm
Nanostring to webcast panel on ai-based genomics and drug discovery from the 43rd annual cowen health care conference
SEATTLE--(BUSINESS WIRE)--NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and ...
March 1, 2023, 6:00 am
Iovance biotherapeutics, inc. (iova) q4 2022 earnings call transcript
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA ) Q4 2022 Earnings Conference Call February 28, 2023 4:30 PM ET Company Participants Sara Pellegrino - Seni...
March 1, 2023, 12:37 am
How abbott labs, abbvie could profit on seizure drug formula
A new study published in Science translational Medicine could introduce a profitable opportunity for ma...
February 17, 2023, 7:02 am
Regeneron pharmaceuticals, inc. (regn) svb securities global biopharma conference (transcript)
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN ) SVB Securities Global Biopharma Conference February 14, 2023 9:20 AM ET Company Participants Ryan Crowe...
February 14, 2023, 3:42 pm
Arrowhead pharmaceuticals, inc. (arwr) q1 2023 earnings call transcript
Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR ) Q1 2023 Earnings Conference Call February 6, 2023 4:30 PM ET Company Participants Vincent Anzalone - Vi...
February 6, 2023, 9:14 pm